Knockdown of LKB1 in cervical cells resulted in decreased sensitivity to metformin, suggesting that metformin can be used as a potential therapeutic to treat cervical cancers, particularly those with normal LKB1 expression16. This evidence concerns the gene STK11 and cervical carcinoma.